Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.84 USD | +8.75% | +9.98% | +55.32% |
04-15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
04-15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- Official Publications